-
Most Recent
Search Results
240 results for bmti
Stop Looking at Who Builds AI – Look at Who Puts It to Work
I’ll explain why the railroad companies went broke, how similar financial pressures are threatening today’s AI giants, and where investors might find the next generation…
What a 19th-Century Magazine Can Teach Us About AI Stocks
Today, Eric explain why the railroads went broke, how similar financial pressures are threatening today’s AI giants, and where investors might find the next generation…
The AI Bargain Hiding in Big Pharma
Investors may not be giving big pharma companies credit for the potential to turn AI-driven innovation into stronger growth and profits. Let’s discover this bargain…
Elon Musk’s Brain-Tech Push Has Me Watching These 2 Small Stocks
Today, Jonathan will show you two public companies on my watchlist: one with a direct connection to a brain-interface developer, and another that makes research…
The $20 Billion AI Scare That Wasn’t
Earnings season kicks off… how the pros trade surprises… the $20 billion AI scare that wasn’t… tankers are earning $1.3 million a day … Louis…
2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private
Neuralink is private, but Butterfly Network and Quantum-Si offer two very different public-market angles on brain-computer interfaces.
OpenAI’s Security Scare Points to 2 Cyber Stocks Worth Buying
Cybersecurity is rapidly becoming one of the most essential areas of investment in AI. In today’s essay, I want to show you where the winners…
Beyond Elon Musk’s Neuralink: Two Public Stocks With a Stake in the Brain Race
Today, I’ll show you two public companies building the future of brain-computer technology: one with a direct connection to a brain-interface developer, and another that…
Beyond Elon Musk’s Neuralink: Two Public Stocks With a Stake in the Brain Race
Jonathan Rose takes us beyond Musk’s company to explore two publicly traded stocks he’s watching. One has a direct business relationship with an OpenAI-backed brain-interface…
Before Elon Musk Takes Neuralink Public, Here’s Where to Look for Profits
Jonathan Rose looks beyond Neuralink at two public companies on his watchlist, explaining what interests him and how their connections and risks differ.
Bank on This Pair of Biotech Bargains
When it comes to small biotechs, one successful product can send its stock soaring. This pair of companies currently have promising treatments on the horizon.
4 Biotechnology Stocks to Buy Now
This week, four Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
Bebe, Apac and JVA Stock All Reach 52-Week Highs
Stocks setting 52-week highs include Apac Customer Service NASDAQ:APAC), Bebe Stores NASDAQ:BEBE, and Coffee Holding Co NASDAQ:JVA.
7 Biotechnology Stocks to Buy Now
Seven Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…
BioMimetic Has Suitors Lying in Wait
A key FDA OK could have the buyout offers rolling in.
The Best Time to Buy AI? When Everyone’s Afraid of It
We find ourselves in an AI paradox: Backlash towards AI is growing even as its usefulness increases. And that puts us investors in a unique…
1 – 10 of 240 results
